ATE194977T1 - 4-amino(alkyl)cyclohexan-1-carboxamidverbindung n und ihre verwendung - Google Patents
4-amino(alkyl)cyclohexan-1-carboxamidverbindung n und ihre verwendungInfo
- Publication number
- ATE194977T1 ATE194977T1 AT92918882T AT92918882T ATE194977T1 AT E194977 T1 ATE194977 T1 AT E194977T1 AT 92918882 T AT92918882 T AT 92918882T AT 92918882 T AT92918882 T AT 92918882T AT E194977 T1 ATE194977 T1 AT E194977T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclohexane
- amino
- alkyl
- coronary
- cerebral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25568991 | 1991-09-06 | ||
| JP14617592 | 1992-05-12 | ||
| PCT/JP1992/001139 WO1993005021A1 (en) | 1991-09-06 | 1992-09-04 | 4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE194977T1 true ATE194977T1 (de) | 2000-08-15 |
Family
ID=26477067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92918882T ATE194977T1 (de) | 1991-09-06 | 1992-09-04 | 4-amino(alkyl)cyclohexan-1-carboxamidverbindung n und ihre verwendung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5478838A (de) |
| EP (1) | EP0641781B1 (de) |
| KR (2) | KR940702451A (de) |
| AT (1) | ATE194977T1 (de) |
| CA (1) | CA2117096C (de) |
| DE (1) | DE69231297T2 (de) |
| DK (1) | DK0641781T3 (de) |
| ES (1) | ES2148179T3 (de) |
| GR (1) | GR3034633T3 (de) |
| WO (1) | WO1993005021A1 (de) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1195372A1 (de) * | 1994-04-18 | 2002-04-10 | Mitsubishi Pharma Corporation | N-Heterozyklisch substitutierte Benzamid Deriviate mit antihypertensiver Wirkung |
| EP0714898B1 (de) * | 1994-06-21 | 2001-11-14 | Otsuka Pharmaceutical Factory, Inc. | PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE |
| EP0956865B2 (de) | 1996-08-12 | 2010-08-18 | Mitsubishi Tanabe Pharma Corporation | MEDIKAMENTE ENTHALTEND Rho-KINASE INHIBITOREN |
| DE19652374A1 (de) * | 1996-12-04 | 1998-06-10 | Schering Ag | Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung |
| CA2307285C (en) | 1998-08-17 | 2009-03-31 | Senju Pharmaceutical Co., Ltd. | Agent for prophylaxis and treatment of glaucoma |
| US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| CA2404594C (en) * | 2000-03-31 | 2010-12-21 | Mitsubishi Pharma Corporation | Agent for prophylaxis and treatment of renal disease |
| US20020177207A1 (en) * | 2001-03-14 | 2002-11-28 | Myriad Genetics, Incorporated | Tsg101-interacting proteins and use thereof |
| WO2002083175A1 (fr) * | 2001-04-11 | 2002-10-24 | Senju Pharmaceutical Co., Ltd. | Agents ameliorant la fonction visuelle |
| CA2483306A1 (en) * | 2002-04-23 | 2003-11-06 | Shionogi & Co., Ltd. | Pyrazolo[1,5-a]pyrimidine derivative and nad(p)h oxidase inhibitor containing the same |
| US20040028716A1 (en) * | 2002-06-14 | 2004-02-12 | Marks Andrew R. | Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation |
| CA2400996A1 (en) * | 2002-09-03 | 2004-03-03 | Lisa Mckerracher | 1,4-substituted cyclohexane derivatives |
| WO2004087707A1 (en) * | 2003-03-31 | 2004-10-14 | Vernalis (Cambridge) Limited | Pyrazolopyrimidine compounds and their use in medicine |
| JP2007502772A (ja) | 2003-08-15 | 2007-02-15 | メルク エンド カムパニー インコーポレーテッド | ４−シクロアルキルアミノピラゾロピリミジンｎｍｄａ／ｎｒ２ｂ拮抗薬 |
| GB0403635D0 (en) * | 2004-02-18 | 2004-03-24 | Devgen Nv | Pyridinocarboxamides with improved activity as kinase inhibitors |
| JP2007523202A (ja) * | 2004-02-24 | 2007-08-16 | ビオアクソン・テラプティーク・インコーポレーテッド | ４置換ピペリジン誘導体 |
| AR054416A1 (es) | 2004-12-22 | 2007-06-27 | Incyte Corp | Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas. |
| JP5071374B2 (ja) * | 2005-07-14 | 2012-11-14 | アステラス製薬株式会社 | ヘテロ環ヤヌスキナーゼ３阻害剤 |
| EP2251341A1 (de) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclische Januskinase-3-Inhibitoren |
| EP1934219A1 (de) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituierte pyrazolo-[3,4-b]-pyridine als phosphodiesterase-inhibitoren |
| US20090036465A1 (en) * | 2006-10-18 | 2009-02-05 | United Therapeutics Corporation | Combination therapy for pulmonary arterial hypertension |
| CA2675288A1 (en) * | 2007-01-12 | 2008-07-17 | Astellas Pharma Inc. | Condensed pyridine compound |
| US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
| US20100272695A1 (en) * | 2009-04-22 | 2010-10-28 | Alan Agulnick | Cell compositions derived from dedifferentiated reprogrammed cells |
| US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| AU2010306627B2 (en) | 2009-10-16 | 2014-07-17 | The Scripps Research Institute | Induction of pluripotent cells |
| AU2010315712B2 (en) | 2009-10-19 | 2014-04-17 | FUJIFILM Cellular Dynamics, Inc. | Cardiomyocyte production |
| DK2582794T3 (en) | 2010-06-15 | 2018-05-22 | Cellular Dynamics Int Inc | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD |
| CN114164167A (zh) | 2010-12-22 | 2022-03-11 | 菲特治疗公司 | 用于单细胞分选与增强ipsc重新编程的细胞培养平台 |
| WO2013009825A1 (en) | 2011-07-11 | 2013-01-17 | Cellular Dynamics International, Inc. | Methods for cell reprogramming and genome engineering |
| CN104640843A (zh) | 2012-07-19 | 2015-05-20 | 大日本住友制药株式会社 | 1-(环烷基羰基)脯氨酸衍生物 |
| US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
| AU2014248167B2 (en) | 2013-04-03 | 2019-10-10 | FUJIFILM Cellular Dynamics, Inc. | Methods and compositions for culturing endoderm progenitor cells in suspension |
| KR20220147728A (ko) | 2014-03-04 | 2022-11-03 | 페이트 세러퓨틱스, 인코포레이티드 | 개선된 재프로그래밍 방법 및 세포 배양 플랫폼 |
| US10106525B2 (en) | 2015-01-26 | 2018-10-23 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| US10857157B2 (en) | 2015-01-26 | 2020-12-08 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| US10149856B2 (en) | 2015-01-26 | 2018-12-11 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| CA3001917A1 (en) | 2015-10-16 | 2017-04-20 | Fate Therapeutics, Inc. | Platform for the induction & maintenance of ground state pluripotency |
| MX2018005274A (es) | 2015-10-30 | 2019-09-19 | The Regents Of The Universtiy Of California | Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t. |
| US11198680B2 (en) | 2016-12-21 | 2021-12-14 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| WO2019014322A1 (en) | 2017-07-11 | 2019-01-17 | BioAxone BioSciences, Inc. | KINASE INHIBITORS FOR THE TREATMENT OF DISEASES |
| UY38427A (es) | 2018-10-26 | 2020-05-29 | Novartis Ag | Métodos y composiciones para terapia con células oculares |
| US20230117572A1 (en) * | 2019-12-30 | 2023-04-20 | Memorial Sloan Kettering Cancer Center | Small molecule inhibitors of ulk1 |
| CN115667504A (zh) | 2020-04-27 | 2023-01-31 | 诺华股份有限公司 | 用于眼细胞疗法的方法和组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6456661A (en) * | 1987-05-29 | 1989-03-03 | Yoshitomi Pharmaceutical | Amino pyridine derivative |
| WO1990005723A1 (en) * | 1988-11-24 | 1990-05-31 | Yoshitomi Pharmaceutical Industries, Ltd. | Trans-4-amino(alkyl)-1-pyridylcarbamoyl-cyclohexane compounds and their medicinal use |
| JP2770497B2 (ja) * | 1988-11-24 | 1998-07-02 | 吉富製薬株式会社 | トランス―４―アミノ（アルキル）―１―ピリジルカルバモイルシクロヘキサン化合物およびその医薬用途 |
-
1992
- 1992-09-04 KR KR1019940700738A patent/KR940702451A/ko not_active IP Right Cessation
- 1992-09-04 DE DE69231297T patent/DE69231297T2/de not_active Expired - Lifetime
- 1992-09-04 WO PCT/JP1992/001139 patent/WO1993005021A1/ja active IP Right Grant
- 1992-09-04 ES ES92918882T patent/ES2148179T3/es not_active Expired - Lifetime
- 1992-09-04 EP EP92918882A patent/EP0641781B1/de not_active Expired - Lifetime
- 1992-09-04 KR KR1019940700738A patent/KR0133372B1/ko active
- 1992-09-04 AT AT92918882T patent/ATE194977T1/de active
- 1992-09-04 US US08/204,211 patent/US5478838A/en not_active Expired - Lifetime
- 1992-09-04 CA CA002117096A patent/CA2117096C/en not_active Expired - Lifetime
- 1992-09-04 DK DK92918882T patent/DK0641781T3/da active
-
2000
- 2000-10-16 GR GR20000402319T patent/GR3034633T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR0133372B1 (ko) | 1998-04-23 |
| DE69231297D1 (de) | 2000-08-31 |
| GR3034633T3 (en) | 2001-01-31 |
| US5478838A (en) | 1995-12-26 |
| KR940702451A (ko) | 1994-08-20 |
| EP0641781A1 (de) | 1995-03-08 |
| DK0641781T3 (da) | 2000-09-18 |
| EP0641781B1 (de) | 2000-07-26 |
| EP0641781A4 (de) | 1994-12-16 |
| CA2117096A1 (en) | 1993-03-18 |
| DE69231297T2 (de) | 2000-11-23 |
| ES2148179T3 (es) | 2000-10-16 |
| WO1993005021A1 (en) | 1993-03-18 |
| CA2117096C (en) | 1997-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE194977T1 (de) | 4-amino(alkyl)cyclohexan-1-carboxamidverbindung n und ihre verwendung | |
| HUT68856A (en) | Acridine derivatives, pharmaceutical compositions comprising the same compouds as effective substances and a process for producing the compounds and the pharmaceutical compositions | |
| ATE164575T1 (de) | Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer | |
| DE69615214T2 (de) | Substituierte heteroaromatische derivate | |
| DE122011100040I2 (de) | Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivitat und zur behandlungvon tumoren. | |
| NO306992B1 (no) | Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene | |
| DE69215694T2 (de) | Benzamid-derivate | |
| NO20020570D0 (no) | Substituerte aromatiske ringforbindelser, fremgangsmåte for fremstilling av samme, og anvendelse | |
| ES2128355T3 (es) | Nuevo derivado bisheterociclico o su sal y composicion hipoglicemica. | |
| ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
| EP0206616A3 (de) | Chinolone mit blutdrucksenkender Wirkung | |
| KR900016227A (ko) | 이소티아졸로피리돈의 아제티딘 유도체, 그의 제조방법 및 의약품으로의 응용 | |
| DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
| EP0525203A4 (en) | Substituted sulfonamide derivative or pharmaceutical composition containing the same | |
| DE69300318T2 (de) | Flavonderivate. | |
| EP0404197A3 (de) | Arylalkylaminderivate | |
| IE42766L (en) | Pharmaceutical preparations | |
| EP0401049A3 (de) | Beta-lactam-Elastase-Inhibitoren | |
| GR3022450T3 (en) | Piperidine derivatives with antihistaminic and antileukohienic activity. | |
| DK0660840T3 (da) | Phosphono-substituerede tetrazolderivater. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEFA | Change of the company name |